title: Effects of prolonged treatment with memantine in the MRL model of CNS lupus.
abstract: Neuropsychiatric manifestations and brain atrophy of unknown etiology are common and severe complications of systemic lupus erythematosus (SLE). An autoantibody that binds to N-methyl-D-aspartate (NMDA) receptor NR2 has been proposed as a key factor in the etiology of central nervous system (CNS) SLE. This hypothesis was supported by evidence suggesting memantine (MEM), an uncompetitive NMDA receptor antagonist, prevents behavioral dysfunction and brain pathology in healthy mice immunized with a peptide similar to an epitope on the NR2 receptor. Given that SLE is a chronic condition, we presently examine the effects of MEM in MRL/lpr mice, which develop behavioral deficits alongside SLE-like disease.
  
  
  
  A broad behavioral battery and 7-Tesla MRI were used to examine whether prolonged treatment with MEM (~25 mg/kg b.w. in drinking water) prevents CNS involvement in this spontaneous model of SLE.
  
  
  
  Although MEM increased novel object exploration in MRL/lpr mice, it did not show other beneficial, substrain-specific effects. Conversely, MEM was detrimental to spontaneous activity in control MRL +/+ mice and had a negative effect on body mass gain. Similarly, MRI revealed comparable increases in the volume of periventricular structures in MEM-treated groups.
  
  
  
  Sustained exposure to MEM affects body growth, brain morphology, and behavior primarily by pharmacological, and not autoimmunity-dependant mechanisms. Substrain-specific improvement in exploratory behavior of MEM-treated MRL/lpr mice may indicate that the NMDA system is merely a constituent of a complex pathogenenic cascade. However, it was evident that chronic administration of MEM is unable to completely prevent the development of a CNS SLE-like syndrome.
authors.affiliation: Department of Psychiatry and Behavioural Neurosciences, McMaster University, Hamilton.
authors.forename: Katarina
authors.initials: K
authors.lastname: Marcinko
authors.forename: Tiffany
authors.initials: T
authors.lastname: Parsons
authors.forename: Jason P
authors.initials: JP
authors.lastname: Lerch
authors.forename: John G
authors.initials: JG
authors.lastname: Sled
authors.forename: Boris
authors.initials: B
authors.lastname: Sakic
keywords: CNS lupus; MRI; animal model; autoimmunity; brain atrophy; glutamate receptor; memantine
references.citation: Semin Arthritis Rheum. 2011 Oct;41(2):194-202
references.pmid: 21458845
references.citation: Brain Res. 2001 Nov 30;920(1-2):183-93
references.pmid: 11716824
references.citation: Physiol Behav. 1996 Sep;60(3):901-5
references.pmid: 8873267
references.citation: J Neuroimmunol. 2005 Dec;169(1-2):68-85
references.pmid: 16198428
references.citation: Behav Neural Biol. 1988 Mar;49(2):139-51
references.pmid: 3365183
references.citation: J Neurol. 2012 Apr;259(4):622-9
references.pmid: 21909801
references.citation: Arthritis Rheum. 2006 Aug;54(8):2505-14
references.pmid: 16868971
references.citation: Epilepsy Res. 2005 Jun;65(1-2):11-22
references.pmid: 15978777
references.citation: Eur Neuropsychopharmacol. 2008 Nov;18(11):794-802
references.pmid: 18573641
references.citation: Nat Med. 2001 Nov;7(11):1189-93
references.pmid: 11689882
references.citation: Brain Res Bull. 1996;41(5):305-11
references.pmid: 8924042
references.citation: Science. 1982 Aug 27;217(4562):855-7
references.pmid: 7100929
references.citation: Ann Rheum Dis. 2005 Aug;64(8):1210-3
references.pmid: 15708887
references.citation: J Neurol Sci. 2010 Aug 15;295(1-2):87-91
references.pmid: 20546792
references.citation: J Neuroimmunol. 2002 Aug;129(1-2):84-96
references.pmid: 12161024
references.citation: Psychopharmacologia. 1975 Jul 23;43(1):53-61
references.pmid: 1099605
references.citation: Physiol Genomics. 2006 Jan 12;24(2):154-62
references.pmid: 16410543
references.citation: Curr Rheumatol Rep. 2007 May;9(2):116-24
references.pmid: 17502041
references.citation: Methods Mol Biol. 2011;711:349-61
references.pmid: 21279611
references.citation: Neuroimage. 2007 Jan 15;34(2):694-701
references.pmid: 17112740
references.citation: Lupus. 2007;16(5):329-34
references.pmid: 17576734
references.citation: Physiol Behav. 1994 Sep;56(3):609-17
references.pmid: 7972416
references.citation: Lupus. 1997;6(3):268-74
references.pmid: 9104735
references.citation: Behav Brain Res. 1993 Mar 31;54(1):57-66
references.pmid: 8504012
references.citation: J Clin Neurol. 2007 Dec;3(4):181-6
references.pmid: 19513129
references.citation: Ann N Y Acad Sci. 1997 Aug 14;823:107-15
references.pmid: 9292037
references.citation: Behav Brain Res. 2006 Jan 6;166(1):32-8
references.pmid: 16183144
references.citation: J Rheumatol. 2006 Aug;33(8):1553-8
references.pmid: 16881112
references.citation: Mol Pharmacol. 1998 Mar;53(3):555-63
references.pmid: 9495824
references.citation: Psychopharmacology (Berl). 1985;86(4):452-7
references.pmid: 3929317
references.citation: Synapse. 2008 Feb;62(2):149-53
references.pmid: 18000814
references.citation: Eur J Neurol. 2005 May;12(5):392-8
references.pmid: 15804272
references.citation: Brain Behav Immun. 1992 Sep;6(3):265-85
references.pmid: 1392101
references.citation: Neurosci Lett. 2001 Jun 22;306(1-2):81-4
references.pmid: 11403963
references.citation: Neuroimage. 2008 Aug 1;42(1):60-9
references.pmid: 18502665
references.citation: J Neuroimmunol. 2010 Dec 15;229(1-2):112-22
references.pmid: 20800292
references.citation: Eur J Pharmacol. 1978 Oct 1;51(3):291-4
references.pmid: 568552
references.citation: J Neuroimmunol. 2000 May 1;104(2):147-54
references.pmid: 10713354
references.citation: J Neuroimmunol. 2006 Oct;179(1-2):26-36
references.pmid: 16904195
references.citation: J Biomed Biotechnol. 2011;2011:207504
references.pmid: 21331367
references.citation: J Rheumatol. 1993 Apr;20(4):610-7
references.pmid: 8496852
references.citation: Behav Brain Res. 2003 Mar 18;140(1-2):119-30
references.pmid: 12644285
references.citation: J Neuroimmunol. 1991 Dec;35(1-3):89-99
references.pmid: 1955574
references.citation: Br J Pharmacol. 2007 May;151(2):253-65
references.pmid: 17375086
references.citation: J Neuroimmunol. 2004 Jul;152(1-2):83-97
references.pmid: 15223241
references.citation: Ann Neurol. 1983 Aug;14(2):242-8
references.pmid: 6625539
references.citation: Physiol Behav. 1995 Oct;58(4):797-802
references.pmid: 8559794
references.citation: Arthritis Rheum. 2009 Jun;60(6):1764-74
references.pmid: 19479832
references.citation: Rheum Dis Clin North Am. 2005 May;31(2):273-98, vi
references.pmid: 15922146
references.citation: Neurosci Biobehav Rev. 1992 Winter;16(4):507-17
references.pmid: 1480347
references.citation: Proc Natl Acad Sci U S A. 2010 Oct 26;107(43):18569-74
references.pmid: 20921396
references.citation: Brain Behav Immun. 1992 Mar;6(1):40-9
references.pmid: 1571603
references.citation: J Neuroimmunol. 1998 Jul 1;87(1-2):162-70
references.pmid: 9670858
references.citation: Clin Immunol Immunopathol. 1997 Oct;85(1):28-34
references.pmid: 9325066
references.citation: Int J Eat Disord. 2008 Sep;41(6):520-6
references.pmid: 18433015
references.citation: Proc Natl Acad Sci U S A. 2006 Dec 26;103(52):19854-9
references.pmid: 17170137
references.citation: Neurosci Biobehav Rev. 1997 May;21(3):327-40
references.pmid: 9168268
references.citation: Neurochem Int. 2007 Jan;50(1):5-11
references.pmid: 16989923
references.citation: Mol Psychiatry. 2008 Nov;13(11):1043-53
references.pmid: 17768421
references.citation: Proc Natl Acad Sci U S A. 2006 Jan 17;103(3):678-83
references.pmid: 16407105
references.citation: Brain Res. 2003 Feb 28;964(2):200-10
references.pmid: 12576180
references.citation: Immunity. 2004 Aug;21(2):179-88
references.pmid: 15308099
references.citation: Neurosci Lett. 2003 Jun 12;343(3):205-9
references.pmid: 12770697
references.citation: J Neuroimmunol. 2005 Aug;165(1-2):104-13
references.pmid: 15972238
references.citation: Brain Res Bull. 2006 Mar 31;69(2):204-13
references.pmid: 16533671
references.citation: J Neuroimmunol. 2003 Sep;142(1-2):67-74
references.pmid: 14512165
references.citation: Arthritis Rheum. 1994 Jun;37(6):889-97
references.pmid: 8003061
references.citation: J Pharmacol Exp Ther. 2004 Nov;311(2):677-82
references.pmid: 15192085
references.citation: Neuroimage. 1999 Aug;10(2):107-13
references.pmid: 10417245